Article Information
History
- June 3, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Martin Friedrichsen1,*,
- Lars Endahl1,
- Frederik Flindt Kreiner1,
- Ronald Goldwater2,
- Martin Kankam3,
- Søren Toubro1 and
- Sune Boris Nygård1
- 1Novo Nordisk A/S, Søborg, Denmark
- 2PAREXEL International, Baltimore, MD, USA
- 3Altasciences Clinical Kansas, Overland Park, KS, USA
- ↵*Corresponding author:
Dr Martin Friedrichsen, Novo Nordisk A/S, Vandtårnsvej 108, Søborg, Denmark. DK-2860, Email:
mfrc{at}novonordisk.com